-transparent.png){kind=logo}
In the transversely cut rat hippocampus, adenosine caused a dose-dependent increase in the accumulation of [3H]cyclic AMP from [3H]ATP. Adenosine breakdown products were inactive. AMP was somewhat less effective than adenosine, and its effect could be partially, but not completely, abolished by alpha, beta-methylene-ADP and GMP, which inhibited its metabolism by 5'-nucleotidase. The effect of adenosine was unaffected by inhibitors of adenosine deaminase, but enhanced by several inhibitors of adenosine uptake. Some analogues of adenosine, including N6-phenylisopropyladenosine (PIA), 2-chloroadenosine and adenosine 5'-ethylcarboxamide (NECA), were more active than adenosine, whereas others such as 2-deoxyadenosine and 9-(tetrahydro-2-furyl)adenine (SQ 22536) actually inhibited the response. The effect of PIA was highly stereospecific. The action of adenosine was inhibited by several alkylxanthines, the most potent of which was 8-phenyltheophylline. [3H]Cyclohexyladenosine (CHA) bound specifically to cell membranes from the rat hippocampus. The extent of binding was similar to that found in other cortical areas. The relative potency of some adenosine analogues and alkylxanthines to displace labelled CHA was essentially similar to their potency as effectors of the cyclic AMP system. Adenosine contributed to the cyclic AMP-elevating effect of alpha-adrenoceptor-stimulating drugs and several amino acids, but not to that seen with isoprenaline. The cyclic AMP increase seen following depolarization was only partially adenosine-dependent. The present results demonstrate that the rat hippocampus contains adenosine receptors mediating cyclic AMP accumulation and that these receptors have similar characteristics to those mediating pyramidal cell depression. Adenosine-induced cyclic AMP accumulation may be used as a biochemical correlate to electrophysiology and as a convenient parameter to assess the influence of drugs on adenosine mechanisms in the rat hippocampus.
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
July 1984,
Naunyn-Schmiedeberg's archives of pharmacology,
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
September 1997,
Neuropharmacology,
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
April 1979,
Agents and actions,
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
January 1997,
Proceedings of the Western Pharmacology Society,
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
November 1978,
Molecular pharmacology,
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
October 1975,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
February 2009,
Neuroreport,
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
November 1995,
The Journal of physiology,
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
April 1991,
Journal of autonomic pharmacology,
B B Fredholm, and
B Jonzon, and
E Lindgren, and
K Lindström
April 2008,
Gastroenterology,
